邁向狙擊之路的个人主页 - 老虎社区

邁向狙擊之路

邁向狙擊之路

暂无个人介绍

IP属地：未知

50关注

39粉丝

0主题

0勋章

邁向狙擊之路

2021-01-05

$Sundial Growers Inc.(SNDL)$睡了晚安😴明早0.55见[微笑]

邁向狙擊之路

2021-07-04

$Marin Software Inc.(MRIN)$下周开盤会是怎樣個走法呢[开心] [财迷]

邁向狙擊之路

2021-07-08

$Exela Technologies, Inc.(XELA)$先睡去了[真香] 明早盘后見4.00希望[财迷] [比心] [比心] 晚安💤大家

邁向狙擊之路

2021-11-05

$Alzamend Neuro, Inc(ALZN)$错过了沒话讲[捂脸] [捂脸]

邁向狙擊之路

2021-07-12

$Exela Technologies, Inc.(XELA)$不管你現在是跌还是漲[微笑] [微笑] 只要沒達到我心目中5美元以上的目標我就是不卖[开心] [开心] [龇牙] [龇牙]

邁向狙擊之路

2021-06-24

$Digital Brands Group, Inc.(DBGI)$繼續飛漲吧[财迷] [财迷] [看涨] [看涨] [看涨]

邁向狙擊之路

2021-08-12

$Exela Technologies, Inc.(XELA)$最新消息[财迷] [财迷]

邁向狙擊之路

2021-06-16

$Cocrystal Pharma, Inc.(COCP)$又見消息出來了[得意] [得意] [财迷] [强] [强]

邁向狙擊之路

2021-05-21

$Yalla Group(YALA)$🈳️头剩3⃣️千票了[开心]

邁向狙擊之路

2021-05-28

$1847 Goedeker(GOED)$這是我看過杀的最多人的1⃣️個股[捂脸] [捂脸] [捂脸]

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3562033051306615","uuid":"3562033051306615","gmtCreate":1598944648669,"gmtModify":1612318091975,"name":"邁向狙擊之路","pinyin":"邁xj擊zl邁xiangju擊zhilu","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":39,"headSize":50,"tweetSize":342,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-2","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资总监虎","description":"证券账户累计交易金额达到30万美元","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"80.50%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.01.15","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.69%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":876023319,"gmtCreate":1637245988115,"gmtModify":1637245988357,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562033051306615","authorIdStr":"3562033051306615"},"themes":[],"title":"","htmlText":"FDA批准了还跌[惊讶]&nbsp;[惊讶]&nbsp;","listText":"FDA批准了还跌[惊讶]&nbsp;[惊讶]&nbsp;","text":"FDA批准了还跌[惊讶] [惊讶]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/876023319","repostId":"2184867063","repostType":2,"isVote":1,"tweetType":1,"viewCount":2804,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":878104086,"gmtCreate":1637156841992,"gmtModify":1637156842191,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562033051306615","authorIdStr":"3562033051306615"},"themes":[],"title":"","htmlText":"是今晚9:00開始嗎？[惊讶]&nbsp;","listText":"是今晚9:00開始嗎？[惊讶]&nbsp;","text":"是今晚9:00開始嗎？[惊讶]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/878104086","repostId":"2184832662","repostType":2,"isVote":1,"tweetType":1,"viewCount":2993,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":842039007,"gmtCreate":1636119750425,"gmtModify":1636119751182,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562033051306615","authorIdStr":"3562033051306615"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/ALZN\">$Alzamend Neuro, Inc(ALZN)$</a>错过了沒话讲[捂脸]&nbsp;[捂脸]&nbsp;","listText":"<a href=\"https://laohu8.com/S/ALZN\">$Alzamend Neuro, Inc(ALZN)$</a>错过了沒话讲[捂脸]&nbsp;[捂脸]&nbsp;","text":"$Alzamend Neuro, Inc(ALZN)$错过了沒话讲[捂脸] [捂脸]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":13,"repostSize":0,"link":"https://laohu8.com/post/842039007","isVote":1,"tweetType":1,"viewCount":2714,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":846773919,"gmtCreate":1636118153675,"gmtModify":1636118478404,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562033051306615","authorIdStr":"3562033051306615"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/XELA\">$Exela Technologies, Inc.(XELA)$</a>什么事[惊讶]&nbsp;突然跌这么多","listText":"<a href=\"https://laohu8.com/S/XELA\">$Exela Technologies, Inc.(XELA)$</a>什么事[惊讶]&nbsp;突然跌这么多","text":"$Exela Technologies, Inc.(XELA)$什么事[惊讶] 突然跌这么多","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/846773919","isVote":1,"tweetType":1,"viewCount":4780,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":846994941,"gmtCreate":1636038439094,"gmtModify":1636038439865,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562033051306615","authorIdStr":"3562033051306615"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/CNDB.U\">$Concord Acquisition Corp III(CNDB.U)$</a><a href=\"https://laohu8.com/U/3581686650032769\">@炮王吴亦凡</a>這妖股還能上天嗎[捂脸]&nbsp;[捂脸]&nbsp;[笑哭]&nbsp;","listText":"<a href=\"https://laohu8.com/S/CNDB.U\">$Concord Acquisition Corp III(CNDB.U)$</a><a href=\"https://laohu8.com/U/3581686650032769\">@炮王吴亦凡</a>這妖股還能上天嗎[捂脸]&nbsp;[捂脸]&nbsp;[笑哭]&nbsp;","text":"$Concord Acquisition Corp III(CNDB.U)$@炮王吴亦凡這妖股還能上天嗎[捂脸] [捂脸] [笑哭]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/846994941","isVote":1,"tweetType":1,"viewCount":2291,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":846998445,"gmtCreate":1636038335285,"gmtModify":1636038335971,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562033051306615","authorIdStr":"3562033051306615"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/CDRE\">$Cadre Holdings Inc(CDRE)$</a>这是什么妖股[捂脸]&nbsp;[捂脸]&nbsp;","listText":"<a href=\"https://laohu8.com/S/CDRE\">$Cadre Holdings Inc(CDRE)$</a>这是什么妖股[捂脸]&nbsp;[捂脸]&nbsp;","text":"$Cadre Holdings Inc(CDRE)$这是什么妖股[捂脸] [捂脸]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/846998445","isVote":1,"tweetType":1,"viewCount":2665,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":848783565,"gmtCreate":1636029537761,"gmtModify":1636029554411,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562033051306615","authorIdStr":"3562033051306615"},"themes":[],"title":"","htmlText":"终于都批准了[财迷]&nbsp;[财迷]&nbsp;[看涨]&nbsp;[看涨]&nbsp;希望一年后能站上$300[捂脸]&nbsp;[捂脸]&nbsp;","listText":"终于都批准了[财迷]&nbsp;[财迷]&nbsp;[看涨]&nbsp;[看涨]&nbsp;希望一年后能站上$300[捂脸]&nbsp;[捂脸]&nbsp;","text":"终于都批准了[财迷] [财迷] [看涨] [看涨] 希望一年后能站上$300[捂脸] [捂脸]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/848783565","repostId":"2180952107","repostType":2,"repost":{"id":"2180952107","kind":"news","pubTimestamp":1636026601,"share":"https://www.laohu8.com/m/news/2180952107?lang=zh_CN&edition=full","pubTime":"2021-11-04 19:50","market":"us","language":"zh","title":"默沙东口服新冠药物molnupiravir在英国获得批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2180952107","media":"界面新闻","summary":"默沙东/Ridgeback宣布英国药品和保健产品监管局(MHRA)已在英国批准molnupiravir (MK-4482, EIDD-2801)上市，用于治疗重症和住院风险较高的轻至中度COVID-19成人患者。Molnupiravir是全球首个获批用于治疗成人轻度至中度COVID-19的口服抗病毒药物，这些患者经SARS-CoV-2诊断测试呈阳性且至少存在一个发展为严重疾病的风险因素。","content":"<div>\n<p>默沙东/Ridgeback宣布英国药品和保健产品监管局(MHRA)已在英国批准molnupiravir (MK-4482, EIDD-2801)上市，用于治疗重症和住院风险较高的轻至中度COVID-19成人患者。Molnupiravir是全球首个获批用于治疗成人轻度至中度COVID-19的口服抗病毒药物，这些患者经SARS-CoV-2诊断测试呈阳性且至少存在一个发展为严重疾病的风险因素。</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202111041951007a06278b&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>默沙东口服新冠药物molnupiravir在英国获得批准</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n默沙东口服新冠药物molnupiravir在英国获得批准\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-04 19:50 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202111041951007a06278b&s=b><strong>界面新闻</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>默沙东/Ridgeback宣布英国药品和保健产品监管局(MHRA)已在英国批准molnupiravir (MK-4482, EIDD-2801)上市，用于治疗重症和住院风险较高的轻至中度COVID-19成人患者。Molnupiravir是全球首个获批用于治疗成人轻度至中度COVID-19的口服抗病毒药物，这些患者经SARS-CoV-2诊断测试呈阳性且至少存在一个发展为严重疾病的风险因素。</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202111041951007a06278b&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/8063c97727cb21de0867e6829ff807e3","relate_stocks":{},"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202111041951007a06278b&s=b","is_english":false,"share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","article_id":"2180952107","content_text":"默沙东/Ridgeback宣布英国药品和保健产品监管局(MHRA)已在英国批准molnupiravir (MK-4482, EIDD-2801)上市，用于治疗重症和住院风险较高的轻至中度COVID-19成人患者。Molnupiravir是全球首个获批用于治疗成人轻度至中度COVID-19的口服抗病毒药物，这些患者经SARS-CoV-2诊断测试呈阳性且至少存在一个发展为严重疾病的风险因素。","news_type":1,"symbols_score_info":{}},"isVote":1,"tweetType":1,"viewCount":2114,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":848547318,"gmtCreate":1636015370264,"gmtModify":1636015370521,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562033051306615","authorIdStr":"3562033051306615"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/BTTX\">$Better Therapeutics(BTTX)$</a>$30冲啊[财迷]&nbsp;[财迷]&nbsp;","listText":"<a href=\"https://laohu8.com/S/BTTX\">$Better Therapeutics(BTTX)$</a>$30冲啊[财迷]&nbsp;[财迷]&nbsp;","text":"$Better Therapeutics(BTTX)$$30冲啊[财迷] [财迷]","images":[{"img":"https://static.tigerbbs.com/d3e492b473cbc91662d8380fac0d9c54","width":"750","height":"1624"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/848547318","isVote":1,"tweetType":1,"viewCount":2090,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":843030540,"gmtCreate":1635781167609,"gmtModify":1635781167807,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562033051306615","authorIdStr":"3562033051306615"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/BTTX\">$Better Therapeutics(BTTX)$</a>去吧[财迷]&nbsp;[财迷]&nbsp;[看涨]&nbsp;[看涨]&nbsp;[看涨]&nbsp;","listText":"<a href=\"https://laohu8.com/S/BTTX\">$Better Therapeutics(BTTX)$</a>去吧[财迷]&nbsp;[财迷]&nbsp;[看涨]&nbsp;[看涨]&nbsp;[看涨]&nbsp;","text":"$Better Therapeutics(BTTX)$去吧[财迷] [财迷] [看涨] [看涨] [看涨]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/843030540","isVote":1,"tweetType":1,"viewCount":2878,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":849713127,"gmtCreate":1635777077882,"gmtModify":1635777078086,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562033051306615","authorIdStr":"3562033051306615"},"themes":[],"title":"","htmlText":"[惊讶]&nbsp;","listText":"[惊讶]&nbsp;","text":"[惊讶]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/849713127","repostId":"1184353503","repostType":2,"isVote":1,"tweetType":1,"viewCount":2133,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":840447524,"gmtCreate":1635680488195,"gmtModify":1635680488475,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562033051306615","authorIdStr":"3562033051306615"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$老虎证券(TIGR)$</a>不懂下星期🈶️沒有机會$5接盘一下下[捂脸]&nbsp;","listText":"<a href=\"https://laohu8.com/S/TIGR\">$老虎证券(TIGR)$</a>不懂下星期🈶️沒有机會$5接盘一下下[捂脸]&nbsp;","text":"$老虎证券(TIGR)$不懂下星期🈶️沒有机會$5接盘一下下[捂脸]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/840447524","isVote":1,"tweetType":1,"viewCount":1641,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":840503679,"gmtCreate":1635654673709,"gmtModify":1635654673911,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562033051306615","authorIdStr":"3562033051306615"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/INND\">$Innerscope Hearing Technologies, Inc.(INND)$</a>你星期一开始还会涨吗[财迷]&nbsp;","listText":"<a href=\"https://laohu8.com/S/INND\">$Innerscope Hearing Technologies, Inc.(INND)$</a>你星期一开始还会涨吗[财迷]&nbsp;","text":"$Innerscope Hearing Technologies, Inc.(INND)$你星期一开始还会涨吗[财迷]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/840503679","isVote":1,"tweetType":1,"viewCount":1554,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":840276599,"gmtCreate":1635654061881,"gmtModify":1635654062072,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562033051306615","authorIdStr":"3562033051306615"},"themes":[],"title":"","htmlText":"[财迷]&nbsp;","listText":"[财迷]&nbsp;","text":"[财迷]","images":[{"img":"https://static.tigerbbs.com/682350ef899b5446132a20f339fc703b","width":"550","height":"866"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/840276599","isVote":1,"tweetType":1,"viewCount":963,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":857650222,"gmtCreate":1635523078940,"gmtModify":1635523079294,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562033051306615","authorIdStr":"3562033051306615"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/AVDL\">$Avadel Pharmaceuticals plc(AVDL)$</a>快乐[开心]&nbsp;","listText":"<a href=\"https://laohu8.com/S/AVDL\">$Avadel Pharmaceuticals plc(AVDL)$</a>快乐[开心]&nbsp;","text":"$Avadel Pharmaceuticals plc(AVDL)$快乐[开心]","images":[{"img":"https://static.tigerbbs.com/dad90f9240447facd8619e644abf6cca","width":"750","height":"1464"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/857650222","isVote":1,"tweetType":1,"viewCount":1427,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":855364626,"gmtCreate":1635338048829,"gmtModify":1635338049017,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562033051306615","authorIdStr":"3562033051306615"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/KAVL\">$Kaival Brands Innovations Group, Inc.(KAVL)$</a>今晚就看你了[开心]&nbsp;[开心]&nbsp;","listText":"<a href=\"https://laohu8.com/S/KAVL\">$Kaival Brands Innovations Group, Inc.(KAVL)$</a>今晚就看你了[开心]&nbsp;[开心]&nbsp;","text":"$Kaival Brands Innovations Group, Inc.(KAVL)$今晚就看你了[开心] [开心]","images":[{"img":"https://static.tigerbbs.com/bf4393ddf27c1a2efff4aea99f96e1a5","width":"750","height":"1624"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/855364626","isVote":1,"tweetType":1,"viewCount":1995,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":855365167,"gmtCreate":1635337992611,"gmtModify":1635337992791,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562033051306615","authorIdStr":"3562033051306615"},"themes":[],"title":"","htmlText":"难怪飞漲的这样快[财迷]&nbsp;FDA过了[财迷]&nbsp;[财迷]&nbsp;","listText":"难怪飞漲的这样快[财迷]&nbsp;FDA过了[财迷]&nbsp;[财迷]&nbsp;","text":"难怪飞漲的这样快[财迷] FDA过了[财迷] [财迷]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/855365167","repostId":"2178426233","repostType":2,"repost":{"id":"2178426233","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"T-Reuters","id":"1086160438","head_image":"https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5"},"pubTimestamp":1635336916,"share":"https://www.laohu8.com/m/news/2178426233?lang=zh_CN&edition=full","pubTime":"2021-10-27 20:15","market":"hk","language":"en","title":"FDA Enters Administrative Stay Of BIDI Vapor's Marketing Denial Order For Its Flavored Ends<blockquote>FDA对BIDI Vapor调味产品的营销拒绝令进行行政中止</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=2178426233","media":"T-Reuters","summary":"Kaival Brands Innovations Group Inc :Fda Enters Administrative Stay Of Bidi Vapor'S Marketing Denial","content":"<p><html><body>Kaival Brands Innovations Group Inc <kavl.o>:Fda Enters Administrative Stay Of Bidi Vapor'S Marketing Denial Order For Its Flavored Ends.Kaival Brands -  Fda Confirmed That While It Reviews Bidi Vapor'S Request, Its Flavored Bidi Sticks Can Remain On Market Without Threat Of Enforcement.</kavl.o></p><p><blockquote><html><body>凯瓦尔品牌创新集团公司<kavl.o>：Fda对Bidi Vapor的调味产品的营销拒绝令进行行政中止。Kaival Brands-FDA证实，在审查Bidi Vapor的请求时，其调味Bidi棒可以继续在市场上销售，而不会受到执法威胁。</kavl.o></body></html></blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>FDA Enters Administrative Stay Of BIDI Vapor's Marketing Denial Order For Its Flavored Ends<blockquote>FDA对BIDI Vapor调味产品的营销拒绝令进行行政中止</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFDA Enters Administrative Stay Of BIDI Vapor's Marketing Denial Order For Its Flavored Ends<blockquote>FDA对BIDI Vapor调味产品的营销拒绝令进行行政中止</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086160438\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">T-Reuters </p>\n<p class=\"h-time smaller\">2021-10-27 20:15</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p><html><body>Kaival Brands Innovations Group Inc <kavl.o>:Fda Enters Administrative Stay Of Bidi Vapor'S Marketing Denial Order For Its Flavored Ends.Kaival Brands -  Fda Confirmed That While It Reviews Bidi Vapor'S Request, Its Flavored Bidi Sticks Can Remain On Market Without Threat Of Enforcement.</kavl.o></p><p><blockquote><html><body>凯瓦尔品牌创新集团公司<kavl.o>：Fda对Bidi Vapor的调味产品的营销拒绝令进行行政中止。Kaival Brands-FDA证实，在审查Bidi Vapor的请求时，其调味Bidi棒可以继续在市场上销售，而不会受到执法威胁。</kavl.o></body></html></blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"KAVL":"Kaival Brands Innovations Group, Inc."},"source_url":"https://www.trkd.thomsonreuters.com","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2178426233","content_text":"Kaival Brands Innovations Group Inc :Fda Enters Administrative Stay Of Bidi Vapor'S Marketing Denial Order For Its Flavored Ends.Kaival Brands -  Fda Confirmed That While It Reviews Bidi Vapor'S Request, Its Flavored Bidi Sticks Can Remain On Market Without Threat Of Enforcement.","news_type":1,"symbols_score_info":{"KAVL":0.9}},"isVote":1,"tweetType":1,"viewCount":1243,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":855393158,"gmtCreate":1635332928388,"gmtModify":1635332928612,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562033051306615","authorIdStr":"3562033051306615"},"themes":[],"title":"","htmlText":"🈶️机会吗[财迷]&nbsp;","listText":"🈶️机会吗[财迷]&nbsp;","text":"🈶️机会吗[财迷]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/855393158","repostId":"2178591283","repostType":2,"repost":{"id":"2178591283","kind":"highlight","pubTimestamp":1635293340,"share":"https://www.laohu8.com/m/news/2178591283?lang=zh_CN&edition=full","pubTime":"2021-10-27 08:09","market":"hk","language":"zh","title":"腾讯阅文洽谈收购米读业务 趣头条“潜力股”存变数？","url":"https://stock-news.laohu8.com/highlight/detail?id=2178591283","media":"Tech星球","summary":"上市后沉寂已久的趣头条，正在迎来新的变化。10月26日，Tech星球独家获悉，腾讯阅文集团正在洽谈收购趣头条的网文业务“米读”，交易已经接近完成。一直以来，阅文与米读、掌阅等平台在免费内容方面有长期合作。如果此次收购达成，将有助于增强阅文的用户基数与IP储备。对此，趣头条和阅文集团均对Tech星球表示，此消息不实，二者仅限于内容合作。但行业信源验证了这一消息真实性，正在进行中。","content":"<html><body><div>\n<p><img border=\"0\" height=\"276\" src=\"https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=105.QTT&amp;imageType=k&amp;token=28dfeb41d35cc81d84b4664d7c23c49f&amp;at=1\" width=\"578\"/></p><p>　　上市后沉寂已久的<span><a href=\"https://laohu8.com/S/QTT\">趣头条</a></span><span></span>，正在迎来新的变化。</p><p>　　10月26日，Tech星球独家获悉，<a href=\"https://laohu8.com/S/00700\">腾讯</a><span><a href=\"https://laohu8.com/S/00772\">阅文集团</a></span>正在洽谈收购<span target=\"_blank\" web=\"1\">趣头条</span>的网文业务“米读”，交易已经接近完成。一直以来，阅文与米读、掌阅等平台在免费内容方面有长期合作。如果此次收购达成，将有助于增强阅文的用户基数与IP储备。</p><p>　　对此，<span target=\"_blank\" web=\"1\">趣头条</span>和<span target=\"_blank\" web=\"1\">阅文集团</span>均对Tech星球表示，此消息不实，二者仅限于内容合作。但行业信源验证了这一消息真实性，正在进行中。</p><p><img border=\"0\" height=\"276\" src=\"https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=116.00772&amp;imageType=k&amp;token=28dfeb41d35cc81d84b4664d7c23c49f&amp;at=1\" width=\"578\"/></p><p>　　在趣头条上市后，股价一路回落，米读可谓撑起了起用户数增长。此次洽谈出售米读业务，公司内外都对此有不同看法。</p><p><strong>趣头条要出售米读业务？</strong></p><p>　　回顾趣头条的发展历程，可谓是兴起于下沉市场，后探索业务多元化以寻增长点。</p><p>　　趣头条最早以金币打赏模式，迅速占据了下沉市场的新闻资讯App赛道，用了27个月时间完成从App上线到<span>纳斯达克</span><span></span>上市。然而上市后，趣头条市值快速回落，从巅峰的45.88亿美元跌落今天的3亿多美元。</p><p>　　趣头条相比“下沉市场三巨头”中快手与<span><a href=\"https://laohu8.com/S/PDD\">拼多多</a></span><span></span>的千亿市值，则是新闻资讯内容平台的生意模式不性感。</p><p>　　根据趣头条二季度财务数据显示，其二季度营收同比下滑16.6%至12.02亿元，符合市场预期；净亏损2.095亿元，较去年同期小幅收窄。更重要的是，趣头条Q2的DAU同比下滑超30%。</p><p>　　短视频对趣头条主业务的影响较大，如今，<a href=\"https://laohu8.com/S/DYIN\">抖音</a>、快手等短视频产品，挤压资讯类产品的用户使用时长，而且诸如抖音极速版也在使用“网赚”模式拓展用户，这种金币打赏模式对下沉用户的吸引力已经不大。</p><p>　　趣头条积极开展了业务多元化，其关联生态探索的萌推、实惠喵、趣键盘等产品都在此背景下。不过，趣头条旗下增速较快的米读是趣头条的希望。2018年推出的免费阅读App米读小说，公开数据显示，2021年一季度，米读DAU已经突破千万，是趣头条的潜力股。</p><p>　　情形尚且不错的米读，对于外界来说，是一个相对来说吸引人的资产。而对于腾讯阅文，在早期整合起点中文网和QQ阅读等产品后，如今拿下米读也并不意外。相信趣头条也将因此具备更多资源，支撑业务多元化探索。</p><center><img src=\"https://dfscdn.dfcfw.com/download/D25281861554338843917.jpg\" width=\"580\"/></center><p><strong>米读与阅文的 IP 变现路</strong></p><p>　　米读并没有一直甘心仅作免费小说。2020年以来，米读拓展了从网文作品到微短剧的IP孵化链路。</p><p>　　米读在2020年1月就成立了短剧部门，同年4月首个IP微短剧上线。后续联合快手，将平台上《权宠刁妃》《河神的新娘》《秦爷的小哑巴》《重生小甜妻》等44部中腰部作品改编成微短剧，全网播放量超48亿。</p><p>　　据悉，米读开发的IP短剧数量达44部，短剧全网播放量超48亿，环比增长41.18%，全网粉丝总量近2000万，环比增长25%。截至2021年6月，米读签约作者数同比增长52.4%，原创作品数同比增长24.84%。</p><p>　　这与<span target=\"_blank\" web=\"1\">阅文集团</span>的发展思路类似，2020年4月，腾讯集团在阅文内进行管理层换血，同时将付费阅读+买断分成的内容变现模式，变为免费内容引流+IP衍生的流量变现模式，其中IP衍生分为影视、游戏和动漫。</p><p>　　2020年新上任的阅文集团CEO程武，也是腾讯影业CEO，主要使命就是推动阅文的IP衍生变现，尤其是在影视领域的变现。</p><p>　　但富有挑战的地方在于，根据阅文上半年财报显示，阅文自有平台(起点中文网)产品及自营渠道的MAU(平均月活跃用户)同比减少0.3%至截至2.3亿人，其中自有平台产品的MAU由1.3亿人同比减少14.6%至1.14亿人。在大力推行免费的策略下，月活用户的减少值得警惕。</p><p>　　阅文集团CEO程武在财报会电话会议上曾表示，2021年业务重点是增长用户，特别是免费用户方面。收购米读瞬间增加用户数，就显得顺理成章。</p><center><img src=\"https://dfscdn.dfcfw.com/download/D25499129344999273058.jpg\" width=\"580\"/></center><p><strong>网文市场格局面临剧变</strong></p><p>　　目前，免费为主流的网文市场上，已经逐渐形成了两大流派。一是阅文集团免费+IP孵化的模式，这与腾讯的文娱实力分不开，腾讯影业、腾讯动漫、腾讯游戏均有较强的IP开发能力，腾讯视频等提供了很好的发行渠道。</p><p>　　另一派则是新晋崛起的番茄小说。一位网文行业资深人士对Tech星球表示：“番茄小说目前发展比较快，是市场的新变量。”番茄小说走的是广告变现的路线，“番茄小说背靠字节，广告等商业化变现还是不错。”当然，番茄小说在IP储备和开发领域还远逊色于阅文。</p><p>　　在整个网文市场的增长近乎触及天花板的情况下，网文市场的比拼已经远不止在图文内容领域，IP开发能力以及商业化变现，才是决定市场格局的最终变量。</p><p>　　米读在两方面都缺乏靠山，IP开发方面，米读执行的是“二八原则”，也即借助快手合作开发头部的20%作品，余下的则以广告形式变现。在商业化变现方面，财报数据显示，趣头条的广告及市场营收为11.41亿元，与去年同期的13.78亿元相比，同比下降了17.2%。米读对广告投放的吸引力也存在一定的天花板。</p><p>　　在此市场竞争情况下，米读的竞争优势并不明显，加入腾讯阅文的大家庭，似乎是不错的发展路线。</p><p>（文章来源：Tech星球）</p>\n</div></body></html>","source":"eastmoney_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>腾讯阅文洽谈收购米读业务 趣头条“潜力股”存变数？</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n腾讯阅文洽谈收购米读业务 趣头条“潜力股”存变数？\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-27 08:09 北京时间&nbsp;&nbsp;&nbsp;<a href=http://stock.eastmoney.com/a/202110272156318475_0.html><strong>Tech星球</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>上市后沉寂已久的趣头条，正在迎来新的变化。　　10月26日，Tech星球独家获悉，腾讯阅文集团正在洽谈收购趣头条的网文业务“米读”，交易已经接近完成。一直以来，阅文与米读、掌阅等平台在免费内容方面有长期合作。如果此次收购达成，将有助于增强阅文的用户基数与IP储备。　　对此，趣头条和阅文集团均对Tech星球表示，此消息不实，二者仅限于内容合作。但行业信源验证了这一消息真实性，正在进行中。　　在趣头条...</p>\n\n<a href=\"http://stock.eastmoney.com/a/202110272156318475_0.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com///dfscdn.dfcfw.com/download/D24858633465871654021.jpg?op=imageView2&mode=2&width=256&height=256&quality=70&format=png","relate_stocks":{"QTT":"趣头条","TCEHY":"腾讯控股ADR","00700":"腾讯控股"},"source_url":"http://stock.eastmoney.com/a/202110272156318475_0.html","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2178591283","content_text":"上市后沉寂已久的趣头条，正在迎来新的变化。　　10月26日，Tech星球独家获悉，腾讯阅文集团正在洽谈收购趣头条的网文业务“米读”，交易已经接近完成。一直以来，阅文与米读、掌阅等平台在免费内容方面有长期合作。如果此次收购达成，将有助于增强阅文的用户基数与IP储备。　　对此，趣头条和阅文集团均对Tech星球表示，此消息不实，二者仅限于内容合作。但行业信源验证了这一消息真实性，正在进行中。　　在趣头条上市后，股价一路回落，米读可谓撑起了起用户数增长。此次洽谈出售米读业务，公司内外都对此有不同看法。趣头条要出售米读业务？　　回顾趣头条的发展历程，可谓是兴起于下沉市场，后探索业务多元化以寻增长点。　　趣头条最早以金币打赏模式，迅速占据了下沉市场的新闻资讯App赛道，用了27个月时间完成从App上线到纳斯达克上市。然而上市后，趣头条市值快速回落，从巅峰的45.88亿美元跌落今天的3亿多美元。　　趣头条相比“下沉市场三巨头”中快手与拼多多的千亿市值，则是新闻资讯内容平台的生意模式不性感。　　根据趣头条二季度财务数据显示，其二季度营收同比下滑16.6%至12.02亿元，符合市场预期；净亏损2.095亿元，较去年同期小幅收窄。更重要的是，趣头条Q2的DAU同比下滑超30%。　　短视频对趣头条主业务的影响较大，如今，抖音、快手等短视频产品，挤压资讯类产品的用户使用时长，而且诸如抖音极速版也在使用“网赚”模式拓展用户，这种金币打赏模式对下沉用户的吸引力已经不大。　　趣头条积极开展了业务多元化，其关联生态探索的萌推、实惠喵、趣键盘等产品都在此背景下。不过，趣头条旗下增速较快的米读是趣头条的希望。2018年推出的免费阅读App米读小说，公开数据显示，2021年一季度，米读DAU已经突破千万，是趣头条的潜力股。　　情形尚且不错的米读，对于外界来说，是一个相对来说吸引人的资产。而对于腾讯阅文，在早期整合起点中文网和QQ阅读等产品后，如今拿下米读也并不意外。相信趣头条也将因此具备更多资源，支撑业务多元化探索。米读与阅文的 IP 变现路　　米读并没有一直甘心仅作免费小说。2020年以来，米读拓展了从网文作品到微短剧的IP孵化链路。　　米读在2020年1月就成立了短剧部门，同年4月首个IP微短剧上线。后续联合快手，将平台上《权宠刁妃》《河神的新娘》《秦爷的小哑巴》《重生小甜妻》等44部中腰部作品改编成微短剧，全网播放量超48亿。　　据悉，米读开发的IP短剧数量达44部，短剧全网播放量超48亿，环比增长41.18%，全网粉丝总量近2000万，环比增长25%。截至2021年6月，米读签约作者数同比增长52.4%，原创作品数同比增长24.84%。　　这与阅文集团的发展思路类似，2020年4月，腾讯集团在阅文内进行管理层换血，同时将付费阅读+买断分成的内容变现模式，变为免费内容引流+IP衍生的流量变现模式，其中IP衍生分为影视、游戏和动漫。　　2020年新上任的阅文集团CEO程武，也是腾讯影业CEO，主要使命就是推动阅文的IP衍生变现，尤其是在影视领域的变现。　　但富有挑战的地方在于，根据阅文上半年财报显示，阅文自有平台(起点中文网)产品及自营渠道的MAU(平均月活跃用户)同比减少0.3%至截至2.3亿人，其中自有平台产品的MAU由1.3亿人同比减少14.6%至1.14亿人。在大力推行免费的策略下，月活用户的减少值得警惕。　　阅文集团CEO程武在财报会电话会议上曾表示，2021年业务重点是增长用户，特别是免费用户方面。收购米读瞬间增加用户数，就显得顺理成章。网文市场格局面临剧变　　目前，免费为主流的网文市场上，已经逐渐形成了两大流派。一是阅文集团免费+IP孵化的模式，这与腾讯的文娱实力分不开，腾讯影业、腾讯动漫、腾讯游戏均有较强的IP开发能力，腾讯视频等提供了很好的发行渠道。　　另一派则是新晋崛起的番茄小说。一位网文行业资深人士对Tech星球表示：“番茄小说目前发展比较快，是市场的新变量。”番茄小说走的是广告变现的路线，“番茄小说背靠字节，广告等商业化变现还是不错。”当然，番茄小说在IP储备和开发领域还远逊色于阅文。　　在整个网文市场的增长近乎触及天花板的情况下，网文市场的比拼已经远不止在图文内容领域，IP开发能力以及商业化变现，才是决定市场格局的最终变量。　　米读在两方面都缺乏靠山，IP开发方面，米读执行的是“二八原则”，也即借助快手合作开发头部的20%作品，余下的则以广告形式变现。在商业化变现方面，财报数据显示，趣头条的广告及市场营收为11.41亿元，与去年同期的13.78亿元相比，同比下降了17.2%。米读对广告投放的吸引力也存在一定的天花板。　　在此市场竞争情况下，米读的竞争优势并不明显，加入腾讯阅文的大家庭，似乎是不错的发展路线。（文章来源：Tech星球）","news_type":1,"symbols_score_info":{"00700":1,"QTT":1,"TCEHY":1}},"isVote":1,"tweetType":1,"viewCount":1742,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":855302047,"gmtCreate":1635332409789,"gmtModify":1635332409985,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562033051306615","authorIdStr":"3562033051306615"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/XELA\">$Exela Technologies, Inc.(XELA)$</a>不知道又🈶️多少人被套了[捂脸]&nbsp;","listText":"<a href=\"https://laohu8.com/S/XELA\">$Exela Technologies, Inc.(XELA)$</a>不知道又🈶️多少人被套了[捂脸]&nbsp;","text":"$Exela Technologies, Inc.(XELA)$不知道又🈶️多少人被套了[捂脸]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/855302047","isVote":1,"tweetType":1,"viewCount":1125,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":856171655,"gmtCreate":1635165194836,"gmtModify":1635165195578,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562033051306615","authorIdStr":"3562033051306615"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/BENE\">$Benessere Capital Acquisition Corp(BENE)$</a>感觉这个今晚会涨一波[捂脸]&nbsp;","listText":"<a href=\"https://laohu8.com/S/BENE\">$Benessere Capital Acquisition Corp(BENE)$</a>感觉这个今晚会涨一波[捂脸]&nbsp;","text":"$Benessere Capital Acquisition Corp(BENE)$感觉这个今晚会涨一波[捂脸]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/856171655","isVote":1,"tweetType":1,"viewCount":1291,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":856150651,"gmtCreate":1635163148039,"gmtModify":1635163148767,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562033051306615","authorIdStr":"3562033051306615"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/DWAC\">$Digital World Acquisition Corp(DWAC)$</a>8点一到就飞漲[捂脸]&nbsp;","listText":"<a href=\"https://laohu8.com/S/DWAC\">$Digital World Acquisition Corp(DWAC)$</a>8点一到就飞漲[捂脸]&nbsp;","text":"$Digital World Acquisition Corp(DWAC)$8点一到就飞漲[捂脸]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/856150651","isVote":1,"tweetType":1,"viewCount":901,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":338024934,"gmtCreate":1609777777128,"gmtModify":1703740488815,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562033051306615","idStr":"3562033051306615"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/SNDL\">$Sundial Growers Inc.(SNDL)$</a>睡了 晚安😴明早0.55见[微笑]&nbsp;","listText":"<a href=\"https://laohu8.com/S/SNDL\">$Sundial Growers Inc.(SNDL)$</a>睡了 晚安😴明早0.55见[微笑]&nbsp;","text":"$Sundial Growers Inc.(SNDL)$睡了 晚安😴明早0.55见[微笑]","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":20,"commentSize":23,"repostSize":0,"link":"https://laohu8.com/post/338024934","isVote":1,"tweetType":1,"viewCount":4122,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":155986498,"gmtCreate":1625369443714,"gmtModify":1631885073888,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562033051306615","idStr":"3562033051306615"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/MRIN\">$Marin Software Inc.(MRIN)$</a>下周开盤会是怎樣個走法呢[开心]&nbsp;[财迷]&nbsp;","listText":"<a href=\"https://laohu8.com/S/MRIN\">$Marin Software Inc.(MRIN)$</a>下周开盤会是怎樣個走法呢[开心]&nbsp;[财迷]&nbsp;","text":"$Marin Software Inc.(MRIN)$下周开盤会是怎樣個走法呢[开心] [财迷]","images":[{"img":"https://static.tigerbbs.com/389b60d9bad21cfd8a83b8546984f10d","width":"750","height":"1300"}],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":10,"commentSize":16,"repostSize":1,"link":"https://laohu8.com/post/155986498","isVote":1,"tweetType":1,"viewCount":1545,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3553387701150566","authorId":"3553387701150566","name":"才神","avatar":"https://static.tigerbbs.com/fac8301d590c4dfdd3a0f722b51a2767","crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3553387701150566","idStr":"3553387701150566"},"content":"上冲不过25就要走","text":"上冲不过25就要走","html":"上冲不过25就要走"}],"imageCount":1,"langContent":"CN","totalScore":0},{"id":140741625,"gmtCreate":1625677058467,"gmtModify":1631889915747,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562033051306615","idStr":"3562033051306615"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/XELA\">$Exela Technologies, Inc.(XELA)$</a>先睡去了[真香]&nbsp;明早盘后見4.00希望[财迷]&nbsp;[比心]&nbsp;[比心]&nbsp;晚安💤大家","listText":"<a href=\"https://laohu8.com/S/XELA\">$Exela Technologies, Inc.(XELA)$</a>先睡去了[真香]&nbsp;明早盘后見4.00希望[财迷]&nbsp;[比心]&nbsp;[比心]&nbsp;晚安💤大家","text":"$Exela Technologies, Inc.(XELA)$先睡去了[真香] 明早盘后見4.00希望[财迷] [比心] [比心] 晚安💤大家","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":9,"commentSize":10,"repostSize":0,"link":"https://laohu8.com/post/140741625","isVote":1,"tweetType":1,"viewCount":2375,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3560245986941518","authorId":"3560245986941518","name":"馆小鱼","avatar":"https://static.tigerbbs.com/b9bbbe3a96ac3b3ca210c36bb462abf0","crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3560245986941518","idStr":"3560245986941518"},"content":"厉害了 我是不敢过夜 再看一会儿","text":"厉害了 我是不敢过夜 再看一会儿","html":"厉害了 我是不敢过夜 再看一会儿"},{"author":{"id":"3586363134913865","authorId":"3586363134913865","name":"瓶尔小草","avatar":"https://static.tigerbbs.com/e51ce53c9e6d0507ff9ea411b1a4a4bd","crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3586363134913865","idStr":"3586363134913865"},"content":"好梦 [冷漠]","text":"好梦 [冷漠]","html":"好梦 [冷漠]"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":842039007,"gmtCreate":1636119750425,"gmtModify":1636119751182,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562033051306615","idStr":"3562033051306615"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/ALZN\">$Alzamend Neuro, Inc(ALZN)$</a>错过了沒话讲[捂脸]&nbsp;[捂脸]&nbsp;","listText":"<a href=\"https://laohu8.com/S/ALZN\">$Alzamend Neuro, Inc(ALZN)$</a>错过了沒话讲[捂脸]&nbsp;[捂脸]&nbsp;","text":"$Alzamend Neuro, Inc(ALZN)$错过了沒话讲[捂脸] [捂脸]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":13,"repostSize":0,"link":"https://laohu8.com/post/842039007","isVote":1,"tweetType":1,"viewCount":2714,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":146707135,"gmtCreate":1626098493427,"gmtModify":1631884025368,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562033051306615","idStr":"3562033051306615"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/XELA\">$Exela Technologies, Inc.(XELA)$</a>不管你現在是跌还是漲[微笑]&nbsp;[微笑]&nbsp;只要沒達到我心目中5美元以上的目標我就是不卖[开心]&nbsp;[开心]&nbsp;[龇牙]&nbsp;[龇牙]&nbsp;","listText":"<a href=\"https://laohu8.com/S/XELA\">$Exela Technologies, Inc.(XELA)$</a>不管你現在是跌还是漲[微笑]&nbsp;[微笑]&nbsp;只要沒達到我心目中5美元以上的目標我就是不卖[开心]&nbsp;[开心]&nbsp;[龇牙]&nbsp;[龇牙]&nbsp;","text":"$Exela Technologies, Inc.(XELA)$不管你現在是跌还是漲[微笑] [微笑] 只要沒達到我心目中5美元以上的目標我就是不卖[开心] [开心] [龇牙] [龇牙]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":14,"commentSize":3,"repostSize":1,"link":"https://laohu8.com/post/146707135","isVote":1,"tweetType":1,"viewCount":1537,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":126388131,"gmtCreate":1624544610523,"gmtModify":1631888810750,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562033051306615","idStr":"3562033051306615"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/DBGI\">$Digital Brands Group, Inc.(DBGI)$</a>繼續飛漲吧[财迷]&nbsp;[财迷]&nbsp;[看涨]&nbsp;[看涨]&nbsp;[看涨]&nbsp;","listText":"<a href=\"https://laohu8.com/S/DBGI\">$Digital Brands Group, Inc.(DBGI)$</a>繼續飛漲吧[财迷]&nbsp;[财迷]&nbsp;[看涨]&nbsp;[看涨]&nbsp;[看涨]&nbsp;","text":"$Digital Brands Group, Inc.(DBGI)$繼續飛漲吧[财迷] [财迷] [看涨] [看涨] [看涨]","images":[{"img":"https://static.tigerbbs.com/edd85ad3c07339ead0d18d7d77d0efee","width":"750","height":"1300"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":7,"repostSize":0,"link":"https://laohu8.com/post/126388131","isVote":1,"tweetType":1,"viewCount":1228,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":895777736,"gmtCreate":1628776293125,"gmtModify":1631883841375,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562033051306615","idStr":"3562033051306615"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/XELA\">$Exela Technologies, Inc.(XELA)$</a>最新消息[财迷]&nbsp;[财迷]&nbsp;","listText":"<a href=\"https://laohu8.com/S/XELA\">$Exela Technologies, Inc.(XELA)$</a>最新消息[财迷]&nbsp;[财迷]&nbsp;","text":"$Exela Technologies, Inc.(XELA)$最新消息[财迷] [财迷]","images":[{"img":"https://static.tigerbbs.com/c600d8e13ad8bf726febc5ffb25d1bf8","width":"750","height":"1624"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/895777736","isVote":1,"tweetType":1,"viewCount":1548,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3583721639469341","authorId":"3583721639469341","name":"燕风玉琯","avatar":"https://static.tigerbbs.com/dbf6e775ee4ae1e55c71603c66640bf5","crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3583721639469341","idStr":"3583721639469341"},"content":"利好还是利空","text":"利好还是利空","html":"利好还是利空"}],"imageCount":1,"langContent":"CN","totalScore":0},{"id":160281545,"gmtCreate":1623799614987,"gmtModify":1631886936301,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562033051306615","idStr":"3562033051306615"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/COCP\">$Cocrystal Pharma, Inc.(COCP)$</a>又見消息出來了[得意]&nbsp;[得意]&nbsp;[财迷]&nbsp;[强]&nbsp;[强]&nbsp;","listText":"<a href=\"https://laohu8.com/S/COCP\">$Cocrystal Pharma, Inc.(COCP)$</a>又見消息出來了[得意]&nbsp;[得意]&nbsp;[财迷]&nbsp;[强]&nbsp;[强]&nbsp;","text":"$Cocrystal Pharma, Inc.(COCP)$又見消息出來了[得意] [得意] [财迷] [强] [强]","images":[{"img":"https://static.tigerbbs.com/2e57d93a81fa60db077612042f59c5f0","width":"750","height":"1624"},{"img":"https://static.tigerbbs.com/b7faa989a11024e89ee8b4dd04132ba5","width":"750","height":"1624"},{"img":"https://static.tigerbbs.com/9c2d2cd83d76fb4ebc537b01ee713f60","width":"750","height":"1624"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":6,"repostSize":0,"link":"https://laohu8.com/post/160281545","isVote":1,"tweetType":1,"viewCount":1286,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3560245986941518","authorId":"3560245986941518","name":"馆小鱼","avatar":"https://static.tigerbbs.com/b9bbbe3a96ac3b3ca210c36bb462abf0","crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3560245986941518","idStr":"3560245986941518"},"content":"成交量太低了。资金也不进场","text":"成交量太低了。资金也不进场","html":"成交量太低了。资金也不进场"}],"imageCount":3,"langContent":"CN","totalScore":0},{"id":139820038,"gmtCreate":1621607291424,"gmtModify":1634187682470,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562033051306615","idStr":"3562033051306615"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/YALA\">$Yalla Group(YALA)$</a>🈳️头剩3⃣️千票了[开心]&nbsp;","listText":"<a href=\"https://laohu8.com/S/YALA\">$Yalla Group(YALA)$</a>🈳️头剩3⃣️千票了[开心]&nbsp;","text":"$Yalla Group(YALA)$🈳️头剩3⃣️千票了[开心]","images":[{"img":"https://static.tigerbbs.com/791c56dbee15147d4552729d69f5e4e1","width":"750","height":"1624"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/139820038","isVote":1,"tweetType":1,"viewCount":2070,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3495693900287878","authorId":"3495693900287878","name":"胜天壹子","avatar":"https://static.tigerbbs.com/9471de4d7143f843babd30f48306fa8c","crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3495693900287878","idStr":"3495693900287878"},"content":"现在又有4000了","text":"现在又有4000了","html":"现在又有4000了"}],"imageCount":1,"langContent":"CN","totalScore":0},{"id":135820826,"gmtCreate":1622158300865,"gmtModify":1631887563929,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562033051306615","idStr":"3562033051306615"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/GOED\">$1847 Goedeker(GOED)$</a>這是我看過杀的最多人的1⃣️個股[捂脸]&nbsp;[捂脸]&nbsp;[捂脸]&nbsp;","listText":"<a href=\"https://laohu8.com/S/GOED\">$1847 Goedeker(GOED)$</a>這是我看過杀的最多人的1⃣️個股[捂脸]&nbsp;[捂脸]&nbsp;[捂脸]&nbsp;","text":"$1847 Goedeker(GOED)$這是我看過杀的最多人的1⃣️個股[捂脸] [捂脸] [捂脸]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":9,"repostSize":0,"link":"https://laohu8.com/post/135820826","isVote":1,"tweetType":1,"viewCount":2161,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3576915339464459","authorId":"3576915339464459","name":"yqpcnc","avatar":"https://static.tigerbbs.com/a461ab206fa5540b00f31ff42b046f29","crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3576915339464459","idStr":"3576915339464459"},"content":"这是啥情况1","text":"这是啥情况1","html":"这是啥情况1"}],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}